These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38874180)

  • 1. Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment.
    Vomhof M; Boersma AC; Hertroijs DFL; Kaltheuner M; Krichbaum M; Kulzer B; Icks A; Hiligsmann M
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; ():1-11. PubMed ID: 38874180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences of people with Type 2 diabetes for diabetes care: a discrete choice experiment.
    Hertroijs DFL; Elissen AMJ; Brouwers MCGJ; Hiligsmann M; Schaper NC; Ruwaard D
    Diabet Med; 2020 Nov; 37(11):1807-1815. PubMed ID: 31001855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
    Naik-Panvelkar P; Armour C; Rose JM; Saini B
    Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public preferences for primary care provision in Germany - a discrete choice experiment.
    Krinke KS; Tangermann U; Amelung VE; Krauth C
    BMC Fam Pract; 2019 Jun; 20(1):80. PubMed ID: 31185940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs.
    Atkinson-Clark E; Charokopou M; Van Osselaer N; Hiligsmann M
    Epilepsy Behav; 2018 Feb; 79():58-67. PubMed ID: 29248866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.
    Mühlbacher AC; Sadler A; Juhnke C
    Eur J Health Econ; 2021 Apr; 22(3):425-443. PubMed ID: 33587221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
    Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
    J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for pharmacist services to enhance medication management among people with diabetes in Indonesia: A discrete choice experiment.
    Presley B; Groot W; Widjanarko D; Pavlova M
    Patient Educ Couns; 2021 Jul; 104(7):1745-1755. PubMed ID: 33358372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences of People Living with HIV for Long-Acting Antiretroviral Treatment in Germany: Evidence from a Discrete Choice Experiment.
    Emmert M; Rohrbacher S; Jahn J; Fernando K; Lauerer M
    Patient; 2023 Sep; 16(5):537-553. PubMed ID: 37436659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis.
    van Til J; Oudshoorn-Groothuis C; Weernink M; von Birgelen C
    Patient; 2020 Aug; 13(4):445-455. PubMed ID: 32329020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
    Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
    Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
    Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
    JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis.
    Tervonen T; Vora P; Seo J; Krucien N; Marsh K; De Caterina R; Wissinger U; Soriano Gabarró M
    Patient; 2021 Sep; 14(5):661-672. PubMed ID: 33829397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment.
    Sommer J; Dyczmons J; Grobosch S; Gontscharuk V; Vomhof M; Roden M; Icks A
    BMJ Open; 2020 Sep; 10(9):e036995. PubMed ID: 32907900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment.
    Hoedemakers M; Karimi M; Jonker M; Tsiachristas A; Rutten-van Mölken M
    Qual Life Res; 2022 Sep; 31(9):2775-2789. PubMed ID: 35585287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease.
    Gc VS; Iglesias CP; Erdem S; Hassan L; Peek N; Manca A
    Int J Technol Assess Health Care; 2022 Oct; 38(1):e77. PubMed ID: 36286261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences in adolescents and young people's sexual and reproductive health services in Nigeria: a discrete choice experiment.
    Arije O; Madan J; Hlungwani T
    Health Econ Rev; 2024 Mar; 14(1):24. PubMed ID: 38514523
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.